A nationwide Danish register-based cohort study of 156,922 people with a first-time psychiatric hospital diagnosis of depression (ICD-10 F32–F33) found that education level wasn’t tied to antidepressant use before diagnosis — but after diagnosis, those with long education were more likely to receive antidepressant treatment, including newer agents (e.g., vortioxetine), and other specialized care.

Why It Matters To Your Practice

• Educational differences tracked with differences in post-diagnosis treatment intensity and specialization, suggesting inequities in how patients access “high-value” depression care.

• In the 2 years before diagnosis, 72.0% redeemed at least one antidepressant prescription; in the 2 years after diagnosis, 83.8% initiated or continued pharmacologic treatment.

Clinical Benefits

• Patients with long education were more likely after diagnosis to receive newer antidepressants (such as vortioxetine) and MAOIs, and to receive ECT — options that may be appropriate for select patients with more complex or treatment-resistant depression.

• Longer-educated patients more often saw private practicing psychiatrists/psychologists both before and after diagnosis, which may support closer follow-up and psychotherapy access.

Managing Risks

• Don’t let socioeconomic factors become a hidden determinant of step-up care: proactively reassess response, adherence, adverse effects, and access barriers in patients less likely to reach specialty services.

• When considering MAOIs, newer antidepressants, or ECT referral, standardize criteria (severity, prior trials, suicidality, functional impairment) to reduce bias and ensure appropriate escalation.

The Bottom Line

• In this Danish cohort, education level didn’t predict antidepressant prescribing before first hospital depression diagnosis, but long education was linked to greater use of newer antidepressants and other specialized treatments after diagnosis.